| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |